DME Competitive Bidding Demonstration Project Authorized By HR 4954

AdvaMed's support of DME competitive bidding provisions in the House prescription drug benefits package indicates the group's willingness to set aside its concerns with the issue to achieve the larger goal of Medicare inpatient reforms

More from Archive

More from Medtech Insight